Search

Platinum nanoparticles (PtNPs) are one of the widely used NPs, which contribute to potential risks to the aquatic ecosystem. However, PtNPs toxicity in phytoplankton remains inadequately understood, with significant gaps in knowledge regarding their biochemical bases and species-specific responses. Herein, we investigated the impact of PtNPs on two cyanobacterial species (Anabaena laxa and Nostoc muscorum) to explore the harmful pathways triggered by PtNPs in cyanobacteria, which may help in selecting appropriate biomarkers for PtNPs pollution in aquatic environments. We studied the effect of PtNPs on growth, oxidative stress markers, and antioxidant defense systems of the two species. The obtained results showed that PtNPs reduced the level of chlorophyll. Furthermore, they induced dose-dependent oxidative stress to the two species, expressed by significant increases in H 2 O 2 , malondialdehyde (MDA), and protein oxidation (p < 0.05). Stress-induced oxidative damages were more pronounced in N. muscorum, yet the two cyanobacterial species showed higher levels (p < 0.05) of antioxidant metabolites and antioxidant enzymes to combat oxidative stress. Compared to N. muscorum, A. laxa invested more in the induction of antioxidant metabolites including FRAP, polyphenols, flavonoids, and glutathione (GSH), as well as in antioxidant enzymes such as POX, CAT, GR, and GPX. Overall, A. laxa species could be exploited as efficient biomarkers for monitoring PtNPs-induced ecotoxicology. Further investigation of bio-absorption and uptake of PtNPs by microalgae is recommended for developing algae-based bioremediation technologies., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)

To prevent the rapidly increasing prevalence of bacterial resistance, it is crucial to discover new antibacterial agents. The emergence of Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae has been associated with a higher mortality rate in gulf union countries and worldwide. Compared to physical and chemical approaches, green zinc oxide nanoparticle (ZnO-NP) synthesis is thought to be significantly safer and more ecofriendly. The present study used molecular dynamics (MD) to examine how ZnO-NPs interact with porin protein (GLO21), a target of β-lactam antibiotics, and then tested this interaction in vitro by determining the zone of inhibition (IZ), minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC), as well as the alteration of KPC's cell surface. The nanoparticles produced were characterized by UV-Vis spectroscopy, zetasizer, Fourier-transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM). In silico investigation was conducted using a variety of computational techniques, including Autodock Vina for protein and ligand docking and Desmond for MD simulation. The candidate ligands that interact with the GLO21 protein were biosynthesized ZnO-NPs, meropenem, imipenem, and cefepime. Analysis of MD revealed that the ZnO-NPs had the highest log P value (-9.1 kcal/mol), which indicates higher permeability through the bacterial surface, followed by cefepime (-7.9 kcal/mol), meropenem (-7.5 kcal/mol), and imipenem (-6.4 kcal/mol). All tested compounds and ZnO-NPs possess similar binding sites of porin proteins. An MD simulation study showed a stable system for ZnO-NPs and cefepime, as confirmed by RMSD and RMSF values during 100 ns trajectories. The test compounds were further inspected for their intersection with porin in terms of hydrophobic, hydrogen, and ionic levels. In addition, the stability of these bonds were measured by observing the protein-ligand contact within 100 ns trajectories. ZnO-NPs showed promising results for fighting KPC, represented in MIC (0.2 mg/mL), MBC (0.5 mg/mL), and ZI (24 mm diameter). To draw the conclusion that ZnO-NP is a potent antibacterial agent and in order to identify potent antibacterial drugs that do not harm human cells, further in vivo studies are required.

The drugs used to treat cutaneous leishmaniasis (CL) cannot effectively penetrate lesions. Nanogold and nanosilver have been used for treating or enhancing drug delivery in CL. The present study used Commiphora molmol (myrrh) to synthesize silver nanoparticles (MSNPs). The MSNPs were characterized using transmission electron microscopy and energy-dispersive spectroscopy. In addition, antiparasitic effect of myrrh silver nanoparticles (MSNPs) was assessed on Leishmania major both in vitro and in vivo. Five concentrations of MSNPs (10, 50, 80, 100, and 150 μl/100 μL) were used to study their effect on L. major cultures in vitro, and MSNPs were also applied topically to subcutaneous lesions in mice in vivo. The results showed that the MSNPs were 49.09 nm in size. MSNPs, showed a marked and significant (p ≤ 0.05) growth inhibition of L. major promastigotes which was concentration dependent. Overall, the higher concentrations (100, 150 μl/100 μL had a significantly greater inhibitory effect for the MSNPs in comparison to the chemical nanoparticles (CNPs) and pentostam at the same concentrations. Lesions healed completely in 21 d after MSNP treatment in vivo, while pentostam, a commercial drug, and CNPs showed a moderate healing effect on the lesions. Thus, MSNPs were more effective than pentostam and CNPs both in the in vivo and in vitro studies. MSNPs can therefore be promising candidates for various nanomedicine applications., (Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)

Metal oxide nanoparticles have attained notable recognition due to their interesting physicochemical properties. Although these nanoparticles can be synthesized using a variety of approaches, the biological method involving plant extracts is preferred since it provides a simple, uncomplicated, ecologically friendly, efficient, rapid, and economical way for synthesis. In this study, the Azadirachta indica leaf extract was used as a reducing agent, and a green process was used to synthesize tin(ferrous: nickel)dioxide (Sn(Fe : Ni)O2) nanoparticles. The synthesized nanoparticles were subjected to characterization by using X-ray diffraction (XRD), energy-dispersive X-ray (EDX) spectroscopy analysis, field emission scanning electron microscopy (FESEM), Fourier transform infrared (FTIR) spectroscopy, dynamic light scattering (DLS), and photoluminescence (PL) measurement. Furthermore, Sn(Fe : Ni)O2 nanoparticles were analyzed for their antimicrobial activity against Gram-positive and Gram-negative organisms including Staphylococcus aureus, Streptococcus pneumoniae, Bacillus subtilis, Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa bacterial strains. XRD patterns revealed that Sn(Fe : Ni)O2 nanoparticles exhibited a tetragonal structure. The hydrodynamic diameter of the nanoparticles was 143 nm, as confirmed by the DLS spectrum. The FESEM image showed the spherical form of the synthesized nanoparticles. Chemical composites and mapping analyses were performed through the EDAX spectrum. The Sn–O–Sn and Sn–O stretching bands were 615 cm−1 and 550 cm−1 in the FTIR spectrum, respectively. Various surface defects of the synthesized Sn(Fe : Ni)O2 nanoparticles were identified by photoluminescence spectra. Compared to traditional antibiotics like amoxicillin, the inhibition zone revealed that Sn(Fe : Ni)O2 nanoparticles displayed remarkable antibacterial activity against all tested organisms, indicating the valuable potential of nanoparticles in the healthcare industry. [ABSTRACT FROM AUTHOR]